Findings

What do systematic reviews say?

4,919 questions · 13,869 findings · 2,177 reviews · Headline outcomes only

Sort:Best matchNewestHighest certainty Download CSV

No studies found 13,869 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Single‐port laparoscopic hysterectomy vs laparoscopic hysterectomy

Long‐term complications (dichotomous) · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Single‐port laparoscopic hysterectomy vs laparoscopic hysterectomy

Major short‐term complications (dichotomous) · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Total laparoscopic hysterectomy vs laparoscopic‐assisted vaginal hysterectomy

Return to normal activities (days) · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Total laparoscopic hysterectomy vs laparoscopic‐assisted vaginal hysterectomy

Long‐term outcomes · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Total laparoscopic hysterectomy vs laparoscopic‐assisted vaginal hysterectomy

Long‐term complications (dichotomous) · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

V‐NOTES vs laparoscopic hysterectomy

Return to normal activities (days) · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

V‐NOTES vs laparoscopic hysterectomy

Long‐term outcomes · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

V‐NOTES vs laparoscopic hysterectomy

Long‐term complications (dichotomous) · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

V‐NOTES vs laparoscopic hysterectomy

Major short‐term complications (dichotomous) · patients with benign gynaecological disease

The review found no eligible studies for this question.

1 finding from 1 review

Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care

Premature rupture of membranes ‐ not reported · breech presentation

The review found no eligible studies for this question.

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care

Use of oxytocin ‐ not reported · breech presentation

The review found no eligible studies for this question.

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care

Cord blood pH < 7.1 ‐ not reported · breech presentation

The review found no eligible studies for this question.

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care

Need for ECV ‐ not reported · breech presentation

The review found no eligible studies for this question.

1 finding from 1 review

Cephalic version by moxibustion for breech presentation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Leukotriene receptor antagonist vs placebo

Clinical improvement (continuous) · inactive EoE patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Leukotriene receptor antagonist vs placebo

Histological improvement (dichotomous) · inactive EoE patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Leukotriene receptor antagonist vs placebo

Histological improvement (continuous) · inactive EoE patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Leukotriene receptor antagonist vs placebo

Endoscopic improvement (dichotomous) · inactive EoE patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Leukotriene receptor antagonist vs placebo

Endoscopic improvement (continuous) · inactive EoE patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mepolizumab 10 mg/kg vs mepolizumab 0.55 mg/kg

Clinical improvement (dichotomous) · active EoE pediatric patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mepolizumab 10 mg/kg vs mepolizumab 0.55 mg/kg

Clinical improvement (continuous) · active EoE pediatric patients

The review found no eligible studies for this question.

1 finding from 1 review

Medical treatment of eosinophilic esophagitis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found